BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21311095)

  • 21. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
    Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
    Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD26 a cancer stem cell marker and therapeutic target.
    Davies S; Beckenkamp A; Buffon A
    Biomed Pharmacother; 2015 Apr; 71():135-8. PubMed ID: 25960228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?
    Paldino E; Tesori V; Casalbore P; Gasbarrini A; Puglisi MA
    Biomed Res Int; 2014; 2014():859871. PubMed ID: 24527460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.
    Vermeulen L; Todaro M; de Sousa Mello F; Sprick MR; Kemper K; Perez Alea M; Richel DJ; Stassi G; Medema JP
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13427-32. PubMed ID: 18765800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer stemness contributes to cluster formation of colon cancer cells and high metastatic potentials.
    Kapeleris J; Zou H; Qi Y; Gu Y; Li J; Schoning J; Monteiro MJ; Gu W
    Clin Exp Pharmacol Physiol; 2020 May; 47(5):838-847. PubMed ID: 31883392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Alowaidi F; Hashimi SM; Alqurashi N; Alhulais R; Ivanovski S; Bellette B; Meedenyia A; Lam A; Wood S
    Oncol Rep; 2018 Jun; 39(6):2881-2891. PubMed ID: 29693155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells: perspectives for therapeutic targeting.
    Maccalli C; De Maria R
    Cancer Immunol Immunother; 2015 Jan; 64(1):91-7. PubMed ID: 25104304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD133/CD166/Ki-67 triple immunofluorescence assessment for putative cancer stem cells in colon carcinoma.
    Mărgaritescu C; Pirici D; Cherciu I; Bărbălan A; Cârtână T; Săftoiu A
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):161-70. PubMed ID: 24949608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of gastric cancer stem cells using the cell surface marker CD44.
    Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
    Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
    Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
    Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
    Rowehl RA; Burke S; Bialkowska AB; Pettet DW; Rowehl L; Li E; Antoniou E; Zhang Y; Bergamaschi R; Shroyer KR; Ojima I; Botchkina GI
    PLoS One; 2014; 9(6):e99091. PubMed ID: 24921652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
    Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
    Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles.
    Shrestha S; Banstola A; Jeong JH; Seo JH; Yook S
    J Control Release; 2022 Aug; 348():518-536. PubMed ID: 35709876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.